Cardiolyse is a cloud ECG & HRV analytics platform, that enables real-time remote heart health monitoring, providing plain personalized reports, detection and up to two months data-based prognosis on dangerous heart events.
Our groundbreaking ECG analytic technology enables people 45+, their families, healthcare providers and insurance companies:
- To get in-depth snapshot of cardiovascular system state and to monitor its trend;
- Allows making six-month forecast of serious cardiovascular events;
- To learn how current lifestyle is interconnected with heart conditions.
Company Details
- Employees
- 12
- Founded
- 2015
- Address
- Ge Health Innovation Village, 2 Kuortaneenkatu, Helsinki,helsinki 05110,finland
- in****@****yse.com
- Industry
- Wellness And Fitness Services
- NAICS
-
Fitness and Recreational Sports Centers
- Website
- cardiolyse.me
- Keywords
- e-healthcare, cardio analytics, mHealth, MedTech, heart health, Artificial Intelligence, Machine learning, Big data analytics, early diagnosis, occupation health management, Heart disease forecast, GP & Hospital Heart management software, SaaS, healthtech, ecg, healthtech startup, Cardiovascular.
- HQ
- Helsinki, Helsinki
Cardiolyse Questions
Cardiolyse's website is cardiolyse.me
Cardiolyse's LinkedIn profile is https://fi.linkedin.com/company/cardiolyse
Cardiolyse has
12 employees.
View email and phone details for 12
employees at Cardiolyse.
Cardiolyse's industry is
Wellness and Fitness Services
Cardiolyse's top competitors are
Heartbeat.ai,
Delta Technics Oy,
Medrego | Gene & Stem Cell Therapy Innovations,
Ropca,
Endocure Ltd.,
Fuse-Ai,
Vivago Oy,
Medicubex Ltd,
Faceheart,
Caresyntax.
Cardiolyse's support email address is info@cardiolyse.com
Cardiolyse's categories are Wellness and Fitness Services
Cardiolyse's founding year is 2015
